Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dear Menopause

59: Making sense of Menopausal Hormone Therapy (MHT) with Dr Ginni Mansberg

18 May 2023

Description

Has the whole "to MHT or not" conversation left you completely confused and even a little wary?MHT.  HRT.  WTF?!First off, you're not alone. Secondly, this episode with Dr Ginni Mansberg is for you.The author of the bestseller, "The M Word, How to Thrive in Menopause" and founder of science-based Evidence Skincare (ESK), Dr Ginni is an Australian GP, TV presenter, podcaster, author and columnist.As a GP she specialises in all things menopause and all things skin. As a member of both the Australasian and International Menopause Societies and a founding member of the Asia Pacific HPV Coalition, she remains at the cutting edge of women’s health, menopause research and management. In this episode, Ginni and I take a deep dive into Menopause Hormone Therapy. You will learn:What is MHT and is it safe?What types of MHT are available and how do they differ?When you need Oestrogen only treatmentWhen you need a combined Oestrogen and Progesterone treatmentWhen to consider Vaginal Oestrogen TherapyHow to understand dosageThe difference between a pill, patch, gel and pessaryHow long can you take MHT?What happens when you stop taking MHTWeight gain during menopause and lifestyle changes that also support symptom management Resources:Dr Ginni's WebsiteEvidence Skincare (ESK)Don't Sweat ItInstagramFacebookLinkedinOther episodes you may enjoy:58. The neuroscience of menopause53: How to talk to your doctor about menopause49: Menopause and mental healthThank you for listening to my show! Join the conversation on Instagram

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.